0.61% 0.0046

Eyenovia Inc (EYEN)

Eyenovia Inc 주식(EYEN)의 최신 뉴스

Eyenovia Inc (EYEN)

Eyenovia Inc 주식(EYEN)의 최신 뉴스

Eyenovia Inc (EYEN) requires closer examination - US Post News

Eyenovia Inc [EYEN] Chief Executive Officer makes an insider purchase of 27,071 shares worth 14077.0. - Knox Daily

A significant driver of top-line growth: Eyenovia Inc (EYEN) - SETE News

Analyzing Eyenovia Inc (EYEN) After Recent Trading Activity - Knox Daily

EYEN Shares Are Trading Higher Today: What You Need To Know - Benzinga

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization - The Malaysian Reserve

Eyenovia Inc (EYEN) did well last session? - US Post News

Investor’s Delight: Eyenovia Inc (EYEN) Closes Weak at 0.49, Down -3.67 - The Dwinnex

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization - The Manila Times

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization - Quantisnow

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercializati - ACROFAN USA

Eyenovia Announces Taiwan Export License Approval to Begin Shipment to the U.S. of Clobetasol Propionate Ophthalmic Suspension - Vision Monday

Eyenovia Inc [EYEN] Chief Executive Officer makes an insider acquire of 27,071 shares worth 14,077. - Knox Daily

Eyenovia Inc (EYEN) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle

It makes sense and dollars to buy Eyenovia Inc (EYEN) stock - SETE News

Eyenovia Announces Taiwan Export License Approval to - GlobeNewswire

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S. - StockTitan

Was Eyenovia Inc (EYEN)’s session last reading good? - US Post News

What Did We Find About Insider Trading At Eyenovia Inc (NASDAQ: EYEN)? - Stocks Register

Eyenovia appoints Andrew Jones as new CFO - Investing.com India

Eyenovia appoints Andrew Jones as new CFO - Investing.com

Eyenovia appoints Andrew Jones as new CFO By Investing.com - Investing.com Australia

Eyenovia appoints Andrew Jones as new CFO By Investing.com - Investing.com Canada

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer - ForexTV.com

Eyenovia Appoints Andrew Jones as Chief Financial Officer - citybiz

Eyenovia Announces CFO Transition and New Financial Leadership - TipRanks

Eyenovia appoints Andrew Jones as new CFO By Investing.com - Investing.com UK

Eyenovia Announces Appointment of Experienced Finance and - GlobeNewswire

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer - StockTitan

Eyenovia Inc’s latest rating changes from various analysts - Knox Daily

Michael M. Rowe Buys 27,071 Shares of Eyenovia, Inc. (NASDAQ:EYEN) Stock - Defense World

Insider Buying: Rowe Michael M, Eyenovia Inc [EYEN] Chief Executive Officer invested 27,071 shares - Knox Daily

Eyenovia CEO Michael Rowe buys $14k of company stock - Investing.com

Eyenovia CEO Michael Rowe buys $14k of company stock By Investing.com - Investing.com UK

Stocks of Eyenovia Inc (EYEN) are poised to climb above their peers - SETE News

Ratio Analysis: Unpacking Eyenovia Inc (EYEN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Eyenovia Inc’s Shares Reel: -25.43% Quarterly Revenue Decline Amid 40.79M Market Cap - The InvestChronicle

Eyenovia Inc (EYEN) gets rating Initiated from Northland Capital - Knox Daily

EYEN’s price-to-free cash flow ratio: How it affects investment decisions - US Post News

Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery - Quantisnow

Formosa Pharmaceuticals Announces Development Collaboration Agreement with Eyenovia - Quantisnow

Eyenovia Announces Closing of Public Offering - ForexTV.com

Eyenovia Announces Closing of Public Offering - citybiz

Eyenovia Announces Closing of Public Offering - GlobeNewswire

Eyenovia Unveils Updated Corporate Presentation for Stakeholders - TipRanks

A company insider recently bought 1,515,151 shares of Eyenovia Inc [EYEN]. Should You Buy? - Knox Daily

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday? - MSN

Eyenovia (EYEN) Upgraded to Buy: Here's What You Should Know - MSN

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday? - Benzinga

Eyenovia Announces Share Sale for Corporate Development - TipRanks

SEC Form 424B5 filed by Eyenovia Inc. - Quantisnow

Eyenovia announces $5.14 million stock offering - Investing.com

Eyenovia announces $5.14 million stock offering By Investing.com - Investing.com Australia

Eyenovia Prices of $5.14 Million Public Offering - citybiz

Why Eyenovia (EYEN) Stock Is Getting Hammered Today - Benzinga

Eyenovia Announces Pricing of $5.14 Million Public Offering - GlobeNewswire

Eyenovia announces $5.14 million stock offering By Investing.com - Investing.com UK

Eyenovia Announces Pricing of $5.14 Million Public Offering - StockTitan

Is Now The Time To Buy Eyenovia Inc (NASDAQ: EYEN) Stock? - Stocks Register

Eyenovia announces common stock offering - Investing.com

Eyenovia, Inc. Announces Proposed Public Offering - ForexTV.com

Eyenovia, Inc. Announces Proposed Public Offering - GlobeNewswire

Eyenovia, Inc. Announces Proposed Public Offering - StockTitan

Eyenovia Inc (EYEN) receives an Outperform rating from Northland Capital - Knox Daily

EYEN (Eyenovia) Dividends per Share : $0.00 (TTM As of Jun. 2024) - GuruFocus.com

EYEN (Eyenovia) Cash Flow from Operations : $-30.23 Mil (TTM As of Jun. 2024) - GuruFocus.com

Financial Snapshot: Analyzing Eyenovia Inc (EYEN)’s Key Ratio Metrics - The Dwinnex

Q3 2024 Earnings Estimate for Eyenovia, Inc. Issued By Brookline Capital Management (NASDAQ:EYEN) - Defense World

Eyenovia (EYEN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

EYEN과 유사한 종목